Mike Hennessy Sr, Founder and Chairman, MJH Life Sciences | Authors

April 18, 2021

March 19, 2021

In order to properly utilize cancer therapies for personalized care, adequate molecular testing must be performed in patients who are eligible for these therapies, with this necessity becoming more and more prevalent in the treatment of gastrointestinal malignancies.

January 12, 2021

In this issue of ONCOLOGY®, we highlight some of the most important posters and presentations from the 2020 American Society of Hematology Annual Meeting & Exposition.

January 07, 2021

Amid the uncertainty, researchers, clinicians, and pharmaceutical companies rose to face one of the greatest medical challenges of our time.